Fludrocortisone for brain aneurysm bleeding recovery
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a medicine called fludrocortisone to see if it helps people recover after a subarachnoid hemorrhage (a type of brain bleed from an aneurysm). The study is for adults who are already being cared for in an intensive care unit shortly after their aneurysm is treated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You have been diagnosed with a subarachnoid hemorrhage (bleeding around the brain) caused by a brain aneurysm that has been treated.
- You were admitted to the hospital within the last 4 days for this condition.
- You are currently in an intensive care unit or similar critical care setting.
- You are not already taking steroid medications like prednisone, and you have never had an allergic reaction to fludrocortisone.
- You do not have severe heart, liver, or kidney failure, your sodium levels in recent blood tests are not too high or too low, and you are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the drug cilostazol can prevent delayed brain damage in people who have had bleeding from a brain aneurysm. It is for adults who had their aneurysm treated within 72 hours and are in moderate to serious condition.
This trial tests whether placing a small drain in the lower back and giving a clot-dissolving medicine (urokinase) into the fluid around the brain can help people recover from a severe bleeding stroke caused by a brain aneurysm. It is for patients who are treated quickly after the bleed.
This trial studies deferoxamine, a medicine that targets iron-related injury, in people with an aneurysmal subarachnoid hemorrhage (a brain bleed caused by a burst aneurysm). It aims to improve neurologic recovery after the aneurysm is treated.
This trial studies a spinal fluid (CSF) treatment to help prevent dangerous blood-vessel tightening (vasospasm) after a type of brain bleed caused by an aneurysm. If you qualify, the goal is to reduce complications soon after aneurysm repair.
This study tests if a medicine called tirofiban (which helps prevent blood clots) can improve recovery after a brain aneurysm rupture. It is for people who have had their aneurysm treated with a coil and are at risk of a delayed stroke.
This Phase 2 trial tests whether milrinone, a heart-acting medicine, can improve brain blood flow to help prevent delayed brain ischemia after a severe subarachnoid hemorrhage. It may help reduce later brain damage in people who are too ill or sedated for a normal neurologic exam early on.
Hear when a new Aneurysmal Subarachnoid Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.